Valerian and Ocrevus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valerian (valerian) and Ocrevus (ocrelizumab). Common drug interactions include nausea among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Valerian and Ocrevus. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Valerian?

Valerian has active ingredients of valerian. It is often used in insomnia. eHealthMe is studying from 1,271 Valerian users. Check the latest studies of Valerian.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.

On Aug, 01, 2026

14 people who take Valerian and Ocrevus together, and have interactions are studied.

What are the common drug interactions of Valerian and Ocrevus, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Pain in extremity
Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged)
Lipase increased
Neuralgia (pain in one or more nerves)
Rash
Contusion (a type of hematoma of tissue in which capillaries)
Dizziness
Fear
Hypoaesthesia (reduced sense of touch or sensation)

male:

Abdominal pain upper
B-lymphocyte count increased
Heart rate increased
Infection susceptibility increased
Loose tooth
Drug ineffective
Gait disturbance
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

What are the common drug interactions of Valerian and Ocrevus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Constipation
Lymphocyte count decreased
Nausea (feeling of having an urge to vomit)
Pain in extremity
Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged)
Lipase increased

40-49:

Dizziness
Fear
Hypoaesthesia (reduced sense of touch or sensation)
Impaired work ability
Muscular weakness (muscle weakness)
Neuralgia (pain in one or more nerves)
Dry mouth
Rash

50-59:

Drug ineffective
Gait disturbance
Heart rate increased
Infection susceptibility increased
Loose tooth
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Contusion (a type of hematoma of tissue in which capillaries)
Rash
Abdominal pain upper
B-lymphocyte count increased

60+:

Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
Contusion (a type of hematoma of tissue in which capillaries)
Dysphagia (a condition in which swallowing is difficult or painful)
Fall
Headache (pain in head)
Irritable bowel syndrome
Abscess (pus)

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 35.71%
Stress And Anxiety: 4 people, 28.57%
Depression: 4 people, 28.57%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 21.43%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 21.43%
Hypersensitivity: 2 people, 14.29%
Weight Decreased: 1 person, 7.14%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 7.14%
Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 1 person, 7.14%
Neuralgia (pain in one or more nerves): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Valerian and Ocrevus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously